Alkermes (ALKS) Divestments (2015)
Alkermes' (ALKS) quarterly Divestments came in at -$301000.0 in Q4 2015, down 1257.69% on a QoQ basis from $26000.0 in Q3 2015.
Alkermes (ALKS) Divestments (2015) Analysis & Trends
Alkermes (ALKS) has 1 years of Divestments data on file, last reported at -$301000.0 in Q4 2015.
- On a quarterly basis, Divestments changed N/A year-over-year to -$301000.0 in Q4 2015; TTM through Sep 2025 was -$301000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $1.7 million, down 98.26% from the prior year.
- Divestments for Q4 2015 stood at -$301000.0, down from $26000.0 in the prior quarter.
- Over the last five years, Divestments for ALKS reached as high as $26000.0 in Q3 2015 and fell as low as -$301000.0 in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 42.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.28 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 63.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Alkermes | 9.72 Bn | 9.21 Bn | 331.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | -301,000.00 |
| Sep 30, 2015 | 26,000.00 |